Bausch Health Co. Inc. (BHC) Misses Q3 EPS by $1.26, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Bausch Health Companies (BHC) PT Raised to $11 at RBC Capital
November 1, 2024 6:18 AM EDTRBC Capital analyst Doug Miehm raised the price target on Bausch Health Companies (NYSE: BHC) to $11.00 (from $10.00) while maintaining a Sector Perform rating.
The analyst comments "BHC reported Q3 results that were ahead of estimates led by strong performance across all segments. Reported... More
